Related Experiment Video
Updated: Sep 15, 2025

Effect of Artificial Tear Formulations on the Metabolic Activity of Human Corneal Epithelial Cells after Exposure to Desiccation
Published on: May 2, 2020
Immediate Impact of Artificial Tear Composition on Optical Aberrations: A Comparative Study of Lipid and Non-Lipid
José-María Sánchez-González1, María Carmen Sánchez-González2, Concepción De-Hita-Cantalejo2
1Department of Physics of Condensed Matter, Optics Area, University of Seville, Seville, Spain. jsanchez80@us.es.
Introduction:
To evaluate the immediate effects of two artificial tear formulations-mineral oil + hydroxypropyl guar (HP-Guar) and hyaluronic acid (HA) + HP-Guar-on ocular aberrations in healthy participants.
Methods:
A randomized, participant-masked clinical trial was conducted on 98 right eyes of 98 participants (mean age: 27.96 ± 10.00 years). Participants received a single instillation of either a lipid-based (mineral oil + HP-Guar) or non-lipid (HA + HP-Guar) artificial tear solution. Ocular aberrations were measured before and 10 min post-instillation using a wavefront aberrometer (i.Profilerplus®, Carl Zeiss Meditec, Jena, Germany) at pupil diameters of 3 mm and 5 mm. Root mean square (RMS) values for total, low-order, and high-order aberrations were analyzed.
Results:
The mineral oil + HP-Guar formulation significantly reduced total RMS (p < 0.05) and low-order RMS (p < 0.05) at both 3-mm and 5-mm pupil diameters. Notable reductions were observed in defocus (Z20), vertical astigmatism (Z22), and trefoil (Z3-3). Both formulations significantly increased high-order RMS (p < 0.05).
Conclusions:
Lipid-based artificial tears provide superior optical quality by reducing total and low-order ocular aberrations, making them preferable for patients with tear film instability. In contrast, HA-based formulations primarily improve hydration with limited impact on optical performance. Artificial tear selection should consider both symptomatic relief and refractive stability, especially for individuals with high visual demands.
Clinical Trial Registration:
This study was registered as a randomized clinical trial on ClinicalTrials.gov under the identifier NCT06784661, titled the ILEACT study.
Related Concept Videos
Focusing of Light in the Eye
Angle Closure Glaucoma: Treatment
Open Angle Glaucoma: Treatment
Drugs such as carbonic anhydrase inhibitors, α2- and...
Properties of Enantiomers and Optical Activity

